ARCHIVES

In Brief: Cancer An Alteration In Gene Expression, Not Change In Structure, Tulane Biologist Reports

This article is from The Cancer Letter archive.

Vol. 07 No. 13 | March 27, 1981

Download PDF Visit The Full Archive

Related Articles

OAM Director Jacobs To Leave; Cites “Conflict with Conscience”

July 15, 1994

Trastuzumab Increases Risks Of Congestive Heart Failure

August 31, 2012

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

Cancer Prevention Fellowship Program Offers Enhancement

March 8, 1991

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

A Texas Radiation Center’s Survival Move Draws M.D. Anderson Into PPM Competition

February 27, 1998